ProShares UltraShort NASDAQ Biotechnology
16 hedge funds and large institutions have $15.6M invested in ProShares UltraShort NASDAQ Biotechnology in 2014 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
23% more capital invested
Capital invested by funds: $12.7M → $15.6M (+$2.86M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
16
Holding in Top 10
1
Calls
$2.23M
Puts
$488K
Top Buyers
| 1 | +$1.71M | |
| 2 | +$1.04M | |
| 3 | +$774K | |
| 4 |
BMO
Beck Mack & Oliver
New York
|
+$602K |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
+$565K |